FED降息预测竟暗含危机?华尔街大佬:预示衰退即将到来
- 0001年1月1日
注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
派斯双林生物制药股份有限公司(原名:南方双林生物制药股份有限公司)是一家主要从事血液制品研究、开发、生产和销售业务的中国公司。该公司主要产品为人血白蛋白、静注人免疫球蛋白(pH4)、人免疫球蛋白、乙型肝炎人免疫球蛋白、破伤风人免疫球蛋白和狂犬病人免疫球蛋白。该公司主要在中国境内开展业务。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Guan Xin Zhou | 52 | 2018 | Chairman of the Supervisory Board |
Hua Gang Yuan | 50 | 2018 | GM & Non-Independent Director |
Di Wu | 40 | 2021 | Deputy GM & Non-Independent Director |
Shaolan Fu | 81 | 2021 | Chairman |
Li Yang | 52 | 2021 | Non-Independent Director |
Qing He | 49 | 2021 | Independent Director |
Xianan Wang | 57 | 2021 | Independent Director |
Lingmou Huang | 60 | 2018 | Director |
Zuojun Dong | 52 | 2021 | Independent Director |
Jingrui Zhang | 55 | 2021 | Non-Independent Director |
Jun Luo | 43 | 2018 | Non-Independent Director |
Jun Xian Yu | 58 | 2018 | Independent Director |
Huagang Zhang | 61 | 2021 | Non-Independent Director |
Sheng Jie Zhang | 53 | 2018 | Independent Director |
Rui Wang | 36 | 2021 | Supervisor |
Qun Nie | - | 2023 | Non-Independent Director |
Hao Li | - | 2023 | Non-Independent Director |
Zhiqiang Liu | - | 2023 | Non-Independent Director |
Yutian Zhang | - | 2023 | Independent Director |
Qiao Zhou | - | 2023 | Non-Independent Director |
Xiaoying Huang | - | 2023 | Non-Independent Director |
Chao Zuo | - | 2023 | Non-Employee Supervisor |
Suping Zhang | - | 2023 | Non-Employee Supervisor |
Lan Ye | - | 2023 | Non-Independent Director |
Pengyun Yang | 65 | 2021 | Non-Employee Supervisor |
Wenbin Si | - | 2023 | Non-Independent Director |
Hao Feng | - | 2023 | Non-Independent Director |
Wengi Wang | - | 2023 | Independent Director |
Jun Ma | - | 2023 | Independent Director |
Jun Yin | - | 2023 | Independent Director |
Hui Guo | - | 2023 | Non-Employee Supervisor |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核